Jeffrey L. Feike Receives Stock Award at Tevogen Inc (TVGN) — SEC Form 4, Sep 16, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
131K sh
56,435 → 131,435
Equity Change
+132.9%
shares held after vs before
Filing Lag
3 business days
late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Jeffrey L. Feike CIK 0002011766 |
Director
|
Jeffrey L. Feike at Tevogen Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Tevogen Inc
| 2026-07-10 | Award | — | View |
| 2024-12-26 | Award | — | View |
| 2024-02-16 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-09-11 | A - Award/Grant | 75,000 A | $0.00 | — | 131,435 | Direct |
Footnotes (1)
- F1
- Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates. Show more
Related filings at Tevogen Inc
5%+ Holders · 13D/G
2 filers
-
Saadi Ryan H. 91.1%
-
Kirti Desai 6.3%
Other insiders at Tevogen Inc
GET /v1/forms/4/0001123292-26-001304
API docs
View Original SEC Filing